Marker Therapeutics Inc Cash Flow Reinvestment Rate

Latest as of September 2024: 0.00x

Marker Therapeutics Inc cash flow reinvestment rate. Marker Therapeutics Inc (MRKR) has a Cash Flow Reinvestment Rate of 0.00x as of September 2024, reinvesting $1.00 (capex $1.00 ) from operating cash flow of $1.20 Million. Explore Marker Therapeutics Inc debt service capacity to assess how comfortably operating cash covers total debt obligations.

Reinvestment Rate

0.00x
(Capex + Investments) / Operating CF

Total Reinvested

$1.00
Capex + Investments

Operating Cash Flow

$1.20 Million
USD

Capital Expenditures

$1.00
USD

Cash Flow Reinvestment Rate of Marker Therapeutics Inc (2001–2001)

Cash flow reinvestment rate of Marker Therapeutics Inc from 2001 to 2001. Historical reinvestment intensity for Marker Therapeutics Inc across 1 annual periods. Explore Marker Therapeutics Inc (MRKR) capital reinvestment to see what proportion of operating cash flow is directed to capital expenditures.

Marker Therapeutics Inc Cash Flow Reinvestment Rate by Year (2001–2001)

Marker Therapeutics Inc cash flow reinvestment rate by year from 2001 to 2001. Year-by-year capital reinvestment analysis for Marker Therapeutics Inc. For the full cash flow conversion analysis, see MRKR cash flow metrics.

Year Reinvestment Rate Total Reinvested (USD) Operating CF Capex YoY Change
2001 0.00x $0.00 $2.38K $0.00 —
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow